Clinical Trial Update: Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating thalidomide for preventing chemotherapy-induced delayed nausea and vomiting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: China Medical University, China | Conditions: Neoplasms | Phase 3 | Status: COMPLETED